OncoSignature

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 2 Study of ACR-368 in Endometrial AdenocarcinomaNCT05548296Acrivon TherapeuticsPhase 2Recruiting2027-05-30Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.